Majority of UK NICE decisions 'still centered on cost-effectiveness'
This article was originally published in SRA
Executive Summary
A new analysis has found that despite NICE claims that cost-effectiveness is not the only consideration in its health technology assessments (HTAs), cost-effectiveness alone correctly predicted 82% of the decisions made by the HTA body for England and Wales through the end of 2011.